Bcl-2 expression decreases cadherin-mediated cell-cell adhesion

Bcl-2, a member of the apoptosis-regulating family of proteins confers a survival advantage on cells by inhibiting apoptosis. Bcl-2 expression is estrogen-responsive and high in various tumors. Overexpression of Bcl-2 has been associated with the loss of contact inhibition, unregulated growth and foci formation in culture. In this study, we have examined the effects of bcl-2 overexpression and expression on cell-cell adhesion in MCF-7 and MDCK epithelial cell lines respectively. Overexpression of Bcl-2 in estrogen receptor-positive MCF-7 mammary carcinoma cells led to decreased cell surface E-cadherin and the disruption of junctional complexes concurrent with intracellular redistribution of their components. Particularly noticeable, was the partial nuclear localization of the tight junction-associated protein ZO-1 which coincided with upregulation of ErbB2. The expression of this EGF co-receptor is regulated by the ZO-1-associated transcription factor ZONAB. Growth in estrogen-depleted media led to downregulation of Bcl-2 expression and upregulation and membrane localization of all junctional proteins. Similar disruption in junctions, accompanied by decreased transepithelial resistance, was observed when Bcl-2 was expressed in MDCK cells. These results strongly suggest that Bcl-2 expression decreases the level of functional E-cadherin thereby interfering with junction formation. The inhibition of junction formation decreases cell-cell adhesion leading to the loss of contact inhibition, which, in vivo, can lead to unregulated growth and tumorigenesis.

[1]  C. Sorenson,et al.  Focal adhesion kinase, paxillin, and Bcl‐2: Analysis of expression, phosphorylation, and association during morphogenesis , 1999, Developmental dynamics : an official publication of the American Association of Anatomists.

[2]  L. González-Mariscal,et al.  Nuclear localization of the tight junction protein ZO-2 in epithelial cells. , 2002, Experimental cell research.

[3]  Y. Yarden,et al.  The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand‐receptor interactions , 1997, FEBS letters.

[4]  S. Andò,et al.  IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1* , 2001, The Journal of Biological Chemistry.

[5]  B. Geiger,et al.  Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. , 1998, Current opinion in cell biology.

[6]  G. Palumbo,et al.  17β-Estradiol Inhibits Apoptosis in MCF-7 Cells, Inducing bcl-2 Expression via Two Estrogen-Responsive Elements Present in the Coding Sequence , 2000, Molecular and Cellular Biology.

[7]  I. Ellis,et al.  Immunocytochemical localization of BCL‐2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy , 1994, International journal of cancer.

[8]  E. Hammond,et al.  Specific cleavage of gamma catenin by caspases during apoptosis. , 1998, FEBS letters.

[9]  O. Blaschuk,et al.  E-cadherin, estrogens and cancer: is there a connection? , 1994, The Canadian journal of oncology.

[10]  Yosef Yarden,et al.  Molecular mechanisms underlying ErbB2/HER2 action in breast cancer , 2000, Oncogene.

[11]  H. Habermann,et al.  Developmental exposure to estrogens alters epithelial cell adhesion and gap junction proteins in the adult rat prostate. , 2001, Endocrinology.

[12]  E. Rosen,et al.  Indole-3-Carbinol Is a Negative Regulator of Estrogen Receptor-α Signaling in Human Tumor Cells , 2000 .

[13]  Martin Kay,et al.  Morphological Analysis , 1973, COLING.

[14]  S. Takenoshita,et al.  Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-X(L), without alteration of p53 protein levels. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  D. Begg,et al.  Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells. , 1994, Journal of cell science.

[16]  R. Perez-soler,et al.  Disruption of cell adhesion and caspase-mediated proteolysis of beta- and gamma-catenins and APC protein in paclitaxel-induced apoptosis. , 2001, Molecular pharmacology.

[17]  T. Yoneda,et al.  E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. , 1996, Cancer research.

[18]  C. L. Adams,et al.  Cytomechanics of cadherin-mediated cell-cell adhesion. , 1998, Current opinion in cell biology.

[19]  L. Miele.  Regulation of Cell Cycle and Apoptosis , 2003 .

[20]  W. Jiang,et al.  Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  John Calvin Reed,et al.  Estrogen withdrawal‐induced human breast cancer tumour regression in nude mice is prevented by Bcl‐2 , 1998, FEBS letters.

[22]  W J Nelson,et al.  Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells , 1994, The Journal of cell biology.

[23]  John Calvin Reed,et al.  BCL‐2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy , 1996, Journal of cellular biochemistry.

[24]  A. Bauer,et al.  Apoptosis-induced Cleavage of β-Catenin by Caspase-3 Results in Proteolytic Fragments with Reduced Transactivation Potential* , 2000, The Journal of Biological Chemistry.

[25]  L. Altucci,et al.  17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. , 1996, Oncogene.

[26]  M. Daidone,et al.  p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Gelmann,et al.  Alterations in β-Catenin Phosphorylation and Plakoglobin Expression in Human Breast Cancer Cells , 1994 .

[28]  C. Schneider,et al.  Proteolytic processing of the adherens junctions components beta-catenin and gamma-catenin/plakoglobin during apoptosis. , 1998, Cell death and differentiation.

[29]  I. Goldberg,et al.  Indole-3-carbinol is a negative regulator of estrogen receptor-alpha signaling in human tumor cells. , 2000, The Journal of nutrition.

[30]  A. Ávila-Flores,et al.  MAGUK proteins: structure and role in the tight junction. , 2000, Seminars in cell & developmental biology.

[31]  W J Nelson,et al.  Cadherin cell adhesion molecules in differentiation and embryogenesis. , 1996, International review of cytology.

[32]  S. Hirohashi,et al.  c-erbB-2 gene product associates with catenins in human cancer cells. , 1994, Biochemical and biophysical research communications.

[33]  K. Fukuda.  Apoptosis-associated cleavage of beta-catenin in human colon cancer and rat hepatoma cells. , 1999, The international journal of biochemistry & cell biology.

[34]  M. Mareel,et al.  Tamoxifen restores the E-cadherin function in human breast cancer MCF-7/6 cells and suppresses their invasive phenotype. , 1994, Cancer research.

[35]  M. Pasdar,et al.  Plakoglobin Regulates the Expression of the Anti-apoptotic Protein BCL-2* , 2000, The Journal of Biological Chemistry.

[36]  E. Lalani,et al.  bcl-2: role in epithelial differentiation and oncogenesis. , 1996, Human pathology.

[37]  M. Mareel,et al.  Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. , 1995, British Journal of Cancer.

[38]  E. Gelmann,et al.  Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells. , 1994, Cancer research.

[39]  M. Cereijido,et al.  Tight junction formation in cultured epithelial cells (MDCK) , 2005, The Journal of Membrane Biology.

[40]  G. Rossini,et al.  Recovery of cellular E‐cadherin precedes replenishment of estrogen receptor and estrogen‐dependent proliferation of breast cancer cells rescued from a death stimulus , 2002, Journal of cellular physiology.

[41]  M. Farthing,et al.  The E‐cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation , 1999, The Journal of pathology.

[42]  B. Herrmann,et al.  Nuclear localization of β-catenin by interaction with transcription factor LEF-1 , 1996, Mechanisms of Development.

[43]  Joe Rodriguez,et al.  Dismantling Cell–Cell Contacts during Apoptosis Is Coupled to a Caspase-dependent Proteolytic Cleavage of β-Catenin , 1997, The Journal of cell biology.

[44]  M. Arpin,et al.  The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Watt,et al.  Journal of Cell Science , 1996, Nature.

[46]  S. Cory,et al.  Life-or-death decisions by the Bcl-2 protein family. , 2001, Trends in biochemical sciences.

[47]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[48]  N. Hynes,et al.  The biology of erbB-2/neu/HER-2 and its role in cancer. , 1994, Biochimica et biophysica acta.

[49]  M. Itoh,et al.  Functional domains of alpha-catenin required for the strong state of cadherin-based cell adhesion. , 1999 .

[50]  S. Hirohashi,et al.  c-erbB-2 gene product directly associates with beta-catenin and plakoglobin. , 1995, Biochemical and biophysical research communications.

[51]  William Rostène,et al.  Hormonal regulation of apoptosis in breast cells and tissues , 2000, Steroids.

[52]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[53]  A. Wolff,et al.  Use of SERMs for the Adjuvant Therapy of Early‐Stage Breast Cancer , 2001, Annals of the New York Academy of Sciences.

[54]  B. Gumbiner,et al.  Regulation of Cadherin Adhesive Activity , 2000, The Journal of cell biology.

[55]  A. Shimizu,et al.  Altered expression of beta-catenin and c-erbB-2 in early gastric cancer. , 2000, Journal of experimental & clinical cancer research : CR.

[56]  B. Gumbiner,et al.  The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex , 1988, The Journal of cell biology.

[57]  R. Perez-soler,et al.  Disruption of Cell Adhesion and Caspase-Mediated Proteolysis of β- and γ-Catenins and APC Protein in Paclitaxel-Induced Apoptosis , 2001 .

[58]  H. Aberle,et al.  Beta-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor , 1994, The Journal of cell biology.

[59]  R. Traystman,et al.  Estrogen and Bcl-2: Gene Induction and Effect of Transgene in Experimental Stroke , 2001, The Journal of Neuroscience.

[60]  J. Papkoff,et al.  Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly , 1994, The Journal of cell biology.

[61]  D. Andrews,et al.  Cytoplasmic O‐glycosylation prevents cell surface transport of E‐cadherin during apoptosis , 2001, The EMBO journal.

[62]  O. Petersen,et al.  Epithelial membrane polarity: a stable, differentiated feature of an established human breast carcinoma cell line MCF-7. , 1987, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[63]  J. Siliciano,et al.  Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia , 1986, The Journal of cell biology.

[64]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[65]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[66]  Marc D. H. Hansen,et al.  Cell polarity: Versatile scaffolds keep things in place , 1999, Current Biology.

[67]  M. Thangaraju,et al.  Regulation of Acidification and Apoptosis by SHP-1 and Bcl-2* , 1999, The Journal of Biological Chemistry.

[68]  W. Nelson,et al.  Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. , 1991, The Journal of biological chemistry.

[69]  Sven Berg,et al.  A repeating amino acid motif shared by proteins with diverse cellular roles , 1994, Cell.

[70]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[71]  R. Kramer,et al.  Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. , 2002, International journal of oncology.

[72]  M. Sheng,et al.  Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2 , 2000, Nature.

[73]  John Calvin Reed.  Dysregulation of apoptosis in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[74]  Paul Polakis,et al.  The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors , 1999, Oncogene.

[75]  E. Fearon,et al.  Cadherin and catenin alterations in human cancer , 2002, Genes, chromosomes & cancer.

[76]  G. Berx,et al.  The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression , 2001, Breast Cancer Research.

[77]  M. Pasdar,et al.  Plakoglobin: kinetics of synthesis, phosphorylation, stability, and interactions with desmoglein and E-cadherin. , 1995, Cell motility and the cytoskeleton.

[78]  M. Pasdar,et al.  Kinetics of desmosome assembly in Madin-Darby canine kidney epithelial cells: temporal and spatial regulation of desmoplakin organization and stabilization upon cell-cell contact. I. Biochemical analysis , 1988, The Journal of cell biology.

[79]  M. Pasdar,et al.  Desmosome assembly and disassembly are regulated by reversible protein phosphorylation in cultured epithelial cells. , 1995, Cell motility and the cytoskeleton.

[80]  Karl Matter,et al.  The tight junction protein ZO‐1 and an interacting transcription factor regulate ErbB‐2 expression , 2000, The EMBO journal.

[81]  I. Ellis,et al.  Immunocytochemical localization of fos protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy , 1994, International journal of cancer.

[82]  J. Depasquale.  Rearrangement of the F-actin cytoskeleton in estradiol-treated MCF-7 breast carcinoma cells , 1999, Histochemistry and Cell Biology.

[83]  J. Reed,et al.  Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer , 1999, Journal of Mammary Gland Biology and Neoplasia.

[84]  E. White.  Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus , 2001, Oncogene.

[85]  E. Hammond,et al.  Specific cleavage of γ catenin by caspases during apoptosis , 1998 .

[86]  J. Taylor‐Papadimitriou,et al.  Overexpression of ERBB2 in human mammary epithelial cells signals inhibition of transcription of the E-cadherin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[87]  R. Kumar,et al.  Apoptosis in mammary gland and cancer. , 2000, Endocrine-related cancer.

[88]  S. Leach,et al.  Introduction of an APC mutation in mouse colon cells results in downregulation of the tight junction protein, ZO-1 , 2000 .

[89]  L. Larue,et al.  E-cadherin null mutant embryos fail to form a trophectoderm epithelium. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Pasdar,et al.  Regulation of desmosome assembly in epithelial cells: kinetics of synthesis, transport, and stabilization of desmoglein I, a major protein of the membrane core domain , 1989, The Journal of cell biology.

[91]  H. Karasuyama,et al.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors , 1988, European journal of immunology.

[92]  B. Schaffhauser,et al.  Epithelial Mesenchymal Transition by C-Fos Estrogen Receptor Activation Involves Nuclear Translocation of β-Catenin and Upregulation of β-Catenin/Lymphoid Enhancer Binding Factor-1 Transcriptional Activity , 2000, The Journal of cell biology.

[93]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[94]  H. Aberle,et al.  Cadherin‐catenin complex: Protein interactions and their implications for cadherin function , 1996, Journal of cellular biochemistry.

[95]  A. Harris,et al.  bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. , 1994, British Journal of Cancer.

[96]  M. Ikura,et al.  Structural basis of calcium-induced E-cadherin rigidification and dimerization , 1996, Nature.

[97]  H. Koeppen,et al.  MAGI-1: a widely expressed, alternatively spliced tight junction protein. , 2002, Experimental cell research.

[98]  Gerhard Christofori,et al.  A causal role for E-cadherin in the transition from adenoma to carcinoma , 1998, Nature.

[99]  C. Schneider,et al.  Proteolytic processing of the adherens junctions components β-catenin and γ-catenin/plakoglobin during apoptosis , 1998, Cell Death and Differentiation.

[100]  Albert B. Reynolds,et al.  Selective Uncoupling of P120ctn from E-Cadherin Disrupts Strong Adhesion , 2000, The Journal of cell biology.